Post-marketing Study Assessing the Long-Term Safety of Abatacept
NCT02169544 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100000
Last updated 2017-04-25
Summary
The purpose of this study is to evaluate the risk of infections and malignancies among Rheumatoid Arthritis (RA) patients treated with Abatacept compared to other RA treatments.
Conditions
Interventions
- DRUG
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bristol-Myers Squibb · Bristol-Myers Squibb
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-01-31
- Primary Completion
- 2017-02-28
- Completion
- 2017-02-28
More Related Trials
-
Safety Study of Abatacept in Rheumatoid Arthritis Participants
NCT03696173 ·Status: COMPLETED
-
Safety Study of Abatacept to Treat Rheumatoid Arthritis (B)
NCT01088360 ·Status: ACTIVE_NOT_RECRUITING
-
A Post-marketing Study to Assess the Safety of Abatacept in Sweden Using the Swedish Rheumatology Quality Register (SRQ) Register
NCT05413044 ·Status: COMPLETED
-
Abatacept Versus Adalimumab Head-to-Head
NCT00929864 ·Status: COMPLETED ·Phase: PHASE3
-
Safety Study of Abatacept in Sweden
NCT01094795 ·Status: COMPLETED
-
Phase IIIB Subcutaneous Abatacept Monotherapy Study
NCT00547521 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Investigating the Efficacy and Safety of ABT-494 Given With Methotrexate in Subjects With Rheumatoid Arthritis Who Failed Anti-Tumor Necrosis Factor (TNF) Biologic Therapy
NCT01960855 ·Status: COMPLETED ·Phase: PHASE2
-
Abatacept With Methotrexate- Phase IIB
NCT00162266 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Abatacept in Patients With Early Rheumatoid Arthritis
NCT02504268 ·Status: COMPLETED ·Phase: PHASE3
-
Methotrexate-Inadequate Response Study
NCT00559585 ·Status: COMPLETED ·Phase: PHASE3
-
Does Abatacept Induce Regulatory B Cells in Patients With Rheumatoid Arthritis
NCT02885818 ·Status: COMPLETED
-
An Exploratory Study of Changes in Synovial Immune Responses Following BMS-188667 Therapy in Subjects With Active Rheumatoid Arthritis on Background DMARDs Who Have Failed Anti-TNF Therapy
NCT00162201 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 2 Study to Investigate the Safety, Tolerability and Efficacy of ABT-122 in Subjects With Active Psoriatic Arthritis (PsA) Who Have an Inadequate Response to Methotrexate (MTX)
NCT02349451 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacokinetics, Safety and Tolerability Study of Single Dose of Abatacept 125mg Administered Subcutaneously
NCT02805010 ·Status: UNKNOWN ·Phase: PHASE1
-
A Phase III Study of Abatacept in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate
NCT00409838 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase III Study of Abatacept (BMS-188667) in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate
NCT00048568 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Biomarkers to Predict Efficacy of Abatacept in Rheumatoid Arthritis
NCT03882008 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase 3 Study of Abatacept in Chinese Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate
NCT02722694 ·Status: UNKNOWN ·Phase: PHASE3
-
Remission and Joint Damage Progression in Early Rheumatoid Arthritis
NCT00122382 ·Status: COMPLETED ·Phase: PHASE3
-
Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting
NCT02037737 ·Status: COMPLETED
-
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate
NCT02629159 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Efficacy, Pharmacokinetics, Safety, and Immunogenicity Study of Abatacept Administered Subcutaneously to Treat Rheumatoid Arthritis in Japanese Patients
NCT01001832 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study to Determine the Risk of Cancer in Rheumatoid Arthritis (RA) Patients Who Use Abatacept and Other Biologic Agents
NCT03670667 ·Status: COMPLETED
-
Phase I/II Multiple-Dose LEA29Y vs CTLAG4Ig vs Placebo in Rheumatoid Arthritis
NCT00279760 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Phase IIIb Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate
NCT00420199 ·Status: COMPLETED ·Phase: PHASE3